No Data
Soft trends, decline in US stocks, etc. [Emerging Markets Individual Stock Global Strategy]
[Emerging Markets Individual Stocks Global Strategy] Today's Emerging Markets are expected to show a weak performance. In the Tokyo market during the six consecutive holidays, on December 30, 2024, the Dow Inc average dropped by 418.48 points. Profit-taking continues as we approach year-end. On December 31, it fell by 29.51 points. The rise in U.S. long-term interest rates weighed on stock prices. On January 2, 2025, it decreased by 151.95 points. In addition to declines in Apple and Tesla, the speculation of slowing rate cuts added to the burden. Last weekend, on the 3rd, the U.S. stock market rose by 339.86 points (+0
Stocks that moved the previous day part 1 Branding, Makino Milling Machine, Weather News, ETC.
Stock Name <Code> 30-day close ⇒ Compared to the previous day, Polaris HD <3010> 184 +1225 has revised its financial estimates for the fiscal year ending March 2025 upwards. Nagao <6239> 1202 +104 has secured a large order from Screen Internal. Hello's <2742> 4625 +425 reported a positive response to its two-digit profit increase for the third quarter. Palemo HD <2778> 123 -10 has seen a 50.9% decrease in operating profit for the cumulative third quarter. Branding <7067> 1638 +300 Japan Asia Investment <
The Tokyo Stock Exchange Growth Market Index saw a slight increase, performing relatively stronger than the main market on the day.
Tokyo Stock Exchange Growth Market Index 824.57 +1.11 / Volume 0.1 billion 88.98 million shares / Trading value 126.7 billion yen Tokyo Stock Exchange Growth Market 250 Index 644.18 -0.64 / Volume 95.07 million shares / Trading value 93.9 billion yen In today's growth market, the Tokyo Stock Exchange Growth Market Index continued to rise slightly, while the Tokyo Stock Exchange Growth Market 250 Index fell slightly. The number of rising stocks was 399, the number of declining stocks was 172, and the number of unchanged stocks was 34. On the 27th in the USA market, the Dow Inc average was down 333.59 dollars to 4299.
Emerging Markets stocks digest: DWTI surged, Headwater briefly hit the daily limit up.
＜4576＞ DWTI 201 +38 surged sharply. It announced that it received notification from Kowa, the licensee, that the glaucoma and ocular hypertension treatment "Graa Alpha Combination Eye Drops (domestic product name)" has been approved in Thailand for the Rho kinase inhibitor Ripasudil hydrochloride hydrate it developed, which is viewed favorably. The product has been on the domestic market since December 2022 through Kowa, and discussions were held regarding overseas sales. This is the first time the product has obtained approval overseas, and Kowa will continue to.
Weakness, weighed down by factors such as falling US stocks [emerging markets individual stock strategy]
[Emerging Markets Individual Stock Strategy] Today's Emerging Markets are expected to experience a weak performance. In the U.S. stock market on the weekend of the 27th, the Dow Inc fell by 333.59 points (-0.77%) to 42,992.21 dollars, marking a downturn after six days. With limited participants as the year-end approaches, profit-taking selling occurred. In particular, technology stocks were sold off in anticipation of rebalancing for the new fiscal year, dragging down the overall market. The Emerging Markets today are likely to see a dominant selling trend. Given that major indices fell in the U.S. stock market last weekend and that Overseas market.
DWTI, Architects SJ and others.
＜1447＞ Acquisition and cancellation of all remaining subscription rights of the 4th series (with exercise price adjustment clause) of SAAFD. ＜3557＞ Large exercise of the 9th subscription rights (with exercise price adjustment clause) of U&C from the 4th, number of shares delivered, 0.07 million, 2000 shares. ＜4576＞ Approval obtained in Thailand for the glaucoma and ocular hypertension treatment "Grau Alpha combination eye drops (domestic product name)" of DWTI. ＜4586＞ Termination of joint research contract with Medrec Fanpepp. ＜4881＞ Soleasia's downward revision, current period operations.